Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen F Pirollo

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2016
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary CancersArlene Siefker-Radtke, Xin-Qiao Zhang, Charles C Guo, et al.
Cancer|April 24, 2019
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2016
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary CancersArlene Siefker-Radtke, Xin-Qiao Zhang, Charles C Guo, et al.
Cancer|April 24, 2019
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Pageof 4